Sarepta Therapeutics Gross Margin 2010-2024 | SRPT

Sarepta Therapeutics gross margin for the quarter ending September 30, 2024 was 85.91%.

  • Sarepta Therapeutics average gross margin for 2023 was 86.71%, a 1.83% decline from 2022.
  • Sarepta Therapeutics average gross margin for 2022 was 85.15%, a 2% increase from 2021.
  • Sarepta Therapeutics average gross margin for 2021 was 86.89%, a 0.99% decline from 2020.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.

Sarepta Therapeutics Gross Margin 2010-2024 | SRPT

  • Sarepta Therapeutics average gross margin for 2023 was 86.71%, a 1.83% decline from 2022.
  • Sarepta Therapeutics average gross margin for 2022 was 85.15%, a 2% increase from 2021.
  • Sarepta Therapeutics average gross margin for 2021 was 86.89%, a 0.99% decline from 2020.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.